Inogen, Inc. (INGN) financial statements and ratios from SEC XBRL: revenue $348.67M (TTM), net margin -6.5%, revenue growth 3.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $348.67M |
| Net Margin | -6.5% |
| Revenue Growth (YoY) | 3.0% |
| EPS Growth (YoY) | -6.7% |
| FCF Growth (YoY) | -39.0% |
| Price / Book | 0.85 |
| Price / Sales | 0.42 |
| FCF Yield | -3.4% |
| Altman Z-Score | 1.41 (distress) |
| Sector P/E (Healthcare) | 21.6 |
INGN overview · INGN earnings · INGN KPIs · INGN investor relations · INGN ownership · INGN peers · INGN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.